This specificity distinguishes BPC-157 from many other peptides, which often have a more targeted action on only one system
(1) Criteria for the use of vitamin B12 (a) approved value in the treatment of pernicious anaemia only (other conditions are very rare in British general practice)
You do not need to avoid the thigh entirely
No change at a tolerated dose can indicate limited response, but it does not support faster-than-label escalation
For the maximum 2.4mg dose, you need 120 units, which actually exceeds a standard 100-unit syringe
Unfortunately, and ironically with the latest FDA restriction: Only large well-funded companies can afford FDA trials Naturally occurring peptides are hard to patent No patent = no financial incentive No incentive = no approval No approval = no legal compounding Thats the present reality, I hope this regulatory and political standstill will resolved in the coming years